Title : Nationwide Experience With Off-Label Use of Interleukin-1 Targeting Treatment in Familial Mediterranean Fever Patients.

Pub. Date : 2018 Jul

PMID : 28992387






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Anti-IL-1 treatment was used because of colchicine-resistant disease in 84% and amyloidosis in 12% of subjects. Colchicine interleukin 1 alpha Homo sapiens
2 CONCLUSION: Anti-IL-1 treatment is an effective alternative for controlling attacks and decreasing proteinuria in colchicine-resistant FMF patients. Colchicine interleukin 1 alpha Homo sapiens